Structure

InChI Key KLDXJTOLSGUMSJ-JGWLITMVSA-N
Smile O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12
InChI
InChI=1S/C6H10O4/c7-3-1-9-6-4(8)2-10-5(3)6/h3-8H,1-2H2/t3-,4+,5-,6-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C6H10O4
Molecular Weight 146.14
AlogP -1.49
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 0.0
Polar Surface Area 58.92
Molecular species NEUTRAL
Aromatic Rings 0.0
Heavy Atoms 10.0

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Angina, Stable 3 D060050 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Lymphoma, Follicular 2 D008224 ClinicalTrials
Lymphoma, Mantle-Cell 2 D020522 ClinicalTrials
Laryngeal Neoplasms 2 D007822 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 2 D015451 ClinicalTrials
Lymphoma, Large B-Cell, Diffuse 2 D016403 ClinicalTrials
Hypertension 2 D006973 ClinicalTrials
Prostatic Neoplasms 2 D011471 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 1 D064129 ClinicalTrials
Small Cell Lung Carcinoma 1 D055752 ClinicalTrials

Related Entries

Scaffolds

Salt
Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Nervous system disorders
28.64
Musculoskeletal and connective tissue disorders
15.02
General disorders and administration site conditions
7.04
Skin and subcutaneous tissue disorders
6.34
Renal and urinary disorders
6.1
Investigations
4.69
Vascular disorders
4.23
Injury, poisoning and procedural complications
3.99
Cardiac disorders
3.52
Infections and infestations
3.29
Psychiatric disorders
3.05
Gastrointestinal disorders
2.58
Reproductive system and breast disorders
2.11

Cross References

Resources Reference
CAS NUMBER 652-67-5
ChEBI 6060
ChEMBL CHEMBL1200660
DrugBank DB09401
DrugCentral 1501
EPA CompTox DTXSID5046196
FDA SRS WXR179L51S
PubChem 12597
SureChEMBL SCHEMBL15495
ZINC ZINC000018284778